Americans are lacking the transparency, clinical expertise and navigation tools needed to make informed decisions about prescription drugs. That's the problem that the AI-powered pharmacy navigation platform, Scripta Insights, is on a mission to solve, starting with the 105 million Americans who are on self-insured plans. The company announced that it has closed $17 million in Series B funding led by Aquiline, a private investment specialist in financial services and related technologies, bringing Scripta's total funding to date to $42 million. This strategic investment comes on the heels of Scripta's revenue surging more than 100% in 2024, capping a milestone year for the business.